The physiologic basis for treatment of shock associated with myocardial infarction.
D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D006439:Hemodynamics; D006801:Humans; D007022:Hypotension / Q000188:drug therapy; D007545:Isoproterenol / Q000627:therapeutic use; D007799:Lanatosides / Q000627:therapeutic use; D008297:Male; D008729:Methoxamine / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D009638:Norepinephrine / Q000627:therapeutic use; D012769:Shock / Q000188:drug therapy* / Q000209:etiology; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D003911:Dextrans; D007799:Lanatosides; D014662:Vasoconstrictor Agents; D008729:Methoxamine; D007545:Isoproterenol; D009638:Norepinephrine